Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
DaVita Inc. is a U.S.-based healthcare company specializing in kidney care services, primarily for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). The company operates within the healthcare services and renal care industries, delivering outpatient dialysis and related clinical services. DaVita’s core business is providing life-sustaining dialysis treatments, which represent the majority of its revenue, largely reimbursed through government programs such as Medicare, as well as commercial insurers.
Founded in 1994 and originally known as Total Renal Care, Inc., the company was renamed DaVita Inc. in 2000 as part of a strategic repositioning. Over time, DaVita expanded through acquisitions and organic clinic growth to become one of the two dominant dialysis providers in the United States. The company is known for its integrated care model, strong clinical performance metrics, and long-term relationships with nephrologists and healthcare systems, which collectively contribute to its competitive positioning.
Business Operations
DaVita operates primarily through two reportable business segments: U.S. Dialysis and Related Lab Services and International Dialysis. The U.S. segment generates the vast majority of revenue and includes outpatient dialysis clinics, laboratory services, pharmacy services, and value-based care arrangements. Revenue is generated on a per-treatment basis, with reimbursement rates governed by federal payment systems and private payor contracts.
International operations are conducted through wholly owned subsidiaries and joint ventures in multiple countries, providing dialysis services under local healthcare reimbursement frameworks. DaVita owns and operates hundreds of dialysis centers globally and utilizes proprietary clinical protocols, data analytics, and patient management systems. The company has historically maintained minority ownership interests in certain joint ventures and healthcare-related entities, including a long-standing equity stake in HealthCare Partners (now part of Optum), though this investment is non-operational.
Strategic Position & Investments
DaVita’s strategic direction focuses on clinical quality, cost efficiency, and integrated kidney care across the disease lifecycle. Growth initiatives emphasize value-based care models, home dialysis modalities, and earlier-stage CKD management to improve outcomes while reducing total cost of care. The company participates in government-sponsored value-based payment models and collaborates with payors and health systems to manage population health risk.
Historically, DaVita has pursued selective acquisitions of dialysis clinics and invested in ancillary services that support renal care delivery. Capital allocation has also included share repurchases and debt management rather than large-scale transformational acquisitions in recent years. Emerging areas of focus include data-driven care coordination, home-based dialysis technologies, and partnerships aimed at advancing kidney care innovation.
Geographic Footprint
DaVita is headquartered in the United States, with its principal executive offices in Colorado. The company’s largest operational presence is across the United States, where it operates thousands of outpatient dialysis centers serving a broad and diverse patient population. The U.S. market accounts for the majority of revenue and operating income.
Internationally, DaVita has a presence in Asia-Pacific, Latin America, and parts of Europe, operating dialysis clinics in countries such as Brazil, China, Saudi Arabia, and Poland. These international operations are smaller in scale compared to the U.S. business but provide geographic diversification and exposure to long-term global demand growth for renal care services.
Leadership & Governance
DaVita is led by an executive team with extensive experience in healthcare services, operations, and value-based care. The company emphasizes a management philosophy centered on patient-centric care, clinical excellence, and disciplined capital allocation, often referred to internally as its community-oriented operating culture.
Key executives include:
- Javier Rodriguez – President and Chief Executive Officer
- Joel Ackerman – Chief Financial Officer
- Maduemem “Reggie” Coles – Chief Operating Officer
- Katherine M. Broderick – Chief Legal Officer and Corporate Secretary
- Mary O’Connor – Chief Human Resources Officer
DaVita operates under a board-governed structure consistent with U.S. public company standards and maintains governance practices aligned with regulatory requirements and long-term shareholder oversight.